Skip to main content

and
  1. Article

    Open Access

    Invasive vegetation encroachment modulates dual threats faced by island-endemic scaly crickets

    The mechanisms by which non-native species impact island-endemic populations are varied and often convoluted. For effective invertebrate conservation where capacity is limited, it is vital to understand both d...

    Weng Yuen Chin, Vicky Wilkins, Adam Sharp in Biological Invasions (2024)

  2. Article

    Open Access

    Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

    Inflammation is a hallmark of cancer1. In patients with cancer, peripheral blood myeloid expansion, indicated by a high neutrophil-to-lymphocyte ratio, associates with shorter survival and treatment resistance ac...

    Christina Guo, Adam Sharp, Bora Gurel, Mateus Crespo, Ines Figueiredo in Nature (2023)

  3. No Access

    Article

    The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells

    Cancer is highly infiltrated by myeloid-derived suppressor cells (MDSCs). Currently available immunotherapies do not completely eradicate MDSCs. Through a genome-wide analysis of the translatome of prostate ca...

    Daniela Brina, Adele Ponzoni, Martina Troiani, Bianca Calì in Nature Cancer (2023)

  4. Article

    Open Access

    Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth

    Prostate cancer is the most common cancer in men and it is estimated that over 350,000 men worldwide die of prostate cancer every year. There remains an unmet clinical need to improve how clinically significan...

    Emma Scott, Kirsty Hodgson, Beatriz Calle, Helen Turner, Kathleen Cheung in Oncogene (2023)

  5. Article

    Open Access

    Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer

    Androgen receptor (AR) signalling is a key prostate cancer (PC) driver, even in advanced ‘castrate-resistant’ disease (CRPC). To systematically identify microRNAs (miRs) modulating AR activity in lethal diseas...

    Claire E. Fletcher, Eric Sulpice, Stephanie Combe, Akifumi Shibakawa in Oncogene (2019)

  6. No Access

    Article

    Alternative splicing in prostate cancer

    Androgen receptor (AR) splice variants (AR-Vs) have been implicated in the development and progression of metastatic prostate cancer. AR-Vs are truncated isoforms of the AR, a subset of which lack a ligand-bin...

    Alec Paschalis, Adam Sharp, Jonathan C. Welti in Nature Reviews Clinical Oncology (2018)

  7. No Access

    Article

    IL-23 secreted by myeloid cells drives castration-resistant prostate cancer

    Patients with prostate cancer frequently show resistance to androgen-deprivation therapy, a condition known as castration-resistant prostate cancer (CRPC). Acquiring a better understanding of the mechanisms th...

    Arianna Calcinotto, Clarissa Spataro, Elena Zagato, Diletta Di Mitri in Nature (2018)

  8. No Access

    Article

    Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents

    In recent years, the therapeutic options for treating men with metastatic castration-resistant prostate cancer have increased substantially. The hormonal treatments abiraterone acetate and enzalutamide, the ch...

    Zafeiris Zafeiriou, Anuradha Jayaram, Adam Sharp, Johann S. de Bono in Drugs (2016)

  9. No Access

    Article

    A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients

    Erlotinib is active in advanced non-small cell lung cancer (aNSCLC) particularly in patients with EGFR-sensitizing mutations. The thymidylate synthase inhibitors are active in NSCLC, but capecitabine is not well...

    Rajiv Kumar, Shir Kiong Lu, Anna Minchom in Cancer Chemotherapy and Pharmacology (2016)

  10. Article

    Open Access

    Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice

    There is an urgent need to identify molecular signatures in small cell lung cancer (SCLC) that may select patients who are likely to respond to molecularly targeted therapies. In this study, we investigate the...

    Fatma Abdelraouf, Adam Sharp, Manisha Maurya, Debbie Mair in BMC Research Notes (2015)

  11. Article

    Content or technology? Technology every time

    Marketers have been focusing on outputs that deliver an immediate impact, such as content and creative. But if marketing wants to take its rightful place at the boardroom table, it needs to look seriously at t...

    Adam Sharp in Journal of Direct, Data and Digital Marketing Practice (2015)

  12. Article

    Open Access

    Text messaging as a community-based survey tool: a pilot study

    It is not known whether using text messaging to administer real-time survey questions is feasible and acceptable among low-income, urban African American adults.

    Tammy Chang, Weyinshet Gossa, Adam Sharp, Zachary Rowe, Lauren Kohatsu in BMC Public Health (2014)

  13. No Access

    Article

    The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription

    BAG-1 is a multifunctional protein that interacts with a wide range of cellular targets including heat-shock proteins and some nuclear hormone receptors. BAG-1 exists as three major isoforms, BAG-1L, BAG-1M an...

    Ramsey I Cutress, Paul A Townsend, Adam Sharp, Anna Maison, Lynn Wood, Ron Lee in Oncogene (2003)